BioSpace News Archive

Business

Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board

Ocugen, Inc. today announced that Connie Collingsworth, former Chief Operating Officer of the Bill and Melinda Gates Foundation, will join the Company’s Business Advisory Board (BAB).

September 21, 2023

·

3 min read

Drug Development

Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missing eGFR Total Slope Endpoint versus Active Control, Irbesartan

Travere Therapeutics, Inc. announced topline two-year confirmatory secondary endpoint results from the Company’s pivotal head-to-head Phase 3 PROTECT Study of FILSPARI® in IgA nephropathy versus irbesartan.

September 21, 2023

·

19 min read

Business

Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer

Nanoscope Therapeutics Inc. announced the appointment of Samuel Barone, M.D., an accomplished leader in the pharmaceutical space and former FDA official, as Chief Medical Officer.

September 21, 2023

·

3 min read

Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting

Endo International plc (OTC: ENDPQ) announced today that data from clinical studies of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis will be presented during the American Orthopaedic Foot & Ankle Society’s (AOFAS) annual scientific meeting.

September 21, 2023

·

6 min read

Business

Riverside University Health System to Implement FloPatch by Flosonics, Revolutionizing Precision Fluid Management in Sepsis Care

Riverside University Health System is proud to announce the implementation of FloPatch by Flosonics Medical. As a pioneer in adopting new, ground-breaking medical technology, Riverside is making a significant leap forward in healthcare innovation, particularly in the life-saving area of sepsis management.

September 21, 2023

·

3 min read

Business

Essity Chairman Pär Boman declines re-election

Pär Boman has declined re-election as Chairman of Essity’s Board of Directors. He will remain as Chairman of the Board until March 2024.

September 21, 2023

·

1 min read

Policy

Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use

Immutep Limited announces the regulatory authorization of eftilagimod alpha manufactured at commercial 2,000L scale for use in clinical trials across multiple European countries including Germany, Belgium, Denmark, and the United Kingdom.

September 21, 2023

·

2 min read

Policy

argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis

argenx SE announced that Health Canada has issued a Notice of Compliance authorizing VYVGARTⓇ for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive.

September 21, 2023

·

6 min read

Sensorion Announces Webconference on September 25, 2023, and its Participation in Upcoming Investor Conferences in October 2023

Sensorion is pleased to announce it is hosting a webconference on September 25, 2023, and its participation in two upcoming investor conferences in October 2023.

September 21, 2023

·

4 min read

Policy

Key Outcomes From FDA Type A Meeting and Mesoblast Next Steps to Achieve RYONCIL Approval

Mesoblast Limited provided an update on the path to approval for its lead-product candidate remestemcel-L in the treatment of pediatric and adult steroid-refractory acute graft versus host disease, following a Type A meeting held with the United States Food and Drug Administration.

September 21, 2023

·

7 min read